Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase, Sector, Therapeutic Area, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

Clinical Trial Supply & Logistics for Pharmaceutical Market Research Report by Phase, Sector, Therapeutic Area, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

The United States Clinical Trial Supply & Logistics for Pharmaceutical Market size was estimated at USD 5,290.09 million in 2021 and expected to reach USD 5,691.12 million in 2022, and is projected to grow at a CAGR 7.66% to reach USD 8,240.11 million by 2027.

Market Statistics:



The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.


Market Segmentation & Coverage:

This research report categorizes the Clinical Trial Supply & Logistics for Pharmaceutical to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Phase, the market was studied across BA/BE Studies, Phase I, Phase II, Phase III, and Phase IV.

Based on Sector, the market was studied across Clinical Trial Logistics and Distributions, Clinical Trial Manufacturing Services, and Clinical Trial Supply Chain Management.

Based on Therapeutic Area, the market was studied across Blood Disorders, Digestive System Diseases, Infectious and Immune System Diseases, Neurological and Mental Disorders, and Oncology.

Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Trial Supply & Logistics for Pharmaceutical market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trial Supply & Logistics for Pharmaceutical Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market, including Almac Group, AmerisourceBergen Corporation, Bilcare Limited, Biocair International Limited, Catalent, Inc., Clinigen Group PLC, DHL International GmbH by Deutsche Post AG, Eurofins Scientific SE, FedEx Corporation, ICON PLC, Infosys Limited, KLIFO A/S, Lonza Group, Marken, Metrics Contract Services by Mayne Pharma group, Movianto, N-Side, Parexel International Corporation, PCI Pharma Services, Seveillar Clinical Trial Supplies Pvt. Ltd., SIRO Clinpharm Private Limited, Thermo Fisher Scientific, Inc., and UDG Healthcare PLC.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Clinical Trial Supply & Logistics for Pharmaceutical Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
4. What is the competitive strategic window for opportunities in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
5. What are the technology trends and regulatory frameworks in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
6. What is the market share of the leading vendors in the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?
7. What modes and strategic moves are considered suitable for entering the United States Clinical Trial Supply & Logistics for Pharmaceutical Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Phase
6.1. Introduction
6.2. BA/BE Studies
6.3. Phase I
6.4. Phase II
6.5. Phase III
6.6. Phase IV
7. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Sector
7.1. Introduction
7.2. Clinical Trial Logistics and Distributions
7.3. Clinical Trial Manufacturing Services
7.4. Clinical Trial Supply Chain Management
8. Clinical Trial Supply & Logistics for Pharmaceutical Market, by Therapeutic Area
8.1. Introduction
8.2. Blood Disorders
8.3. Digestive System Diseases
8.4. Infectious and Immune System Diseases
8.5. Neurological and Mental Disorders
8.6. Oncology
9. California Clinical Trial Supply & Logistics for Pharmaceutical Market
9.1. Introduction
10. Florida Clinical Trial Supply & Logistics for Pharmaceutical Market
10.1. Introduction
11. Illinois Clinical Trial Supply & Logistics for Pharmaceutical Market
11.1. Introduction
12. New York Clinical Trial Supply & Logistics for Pharmaceutical Market
12.1. Introduction
13. Ohio Clinical Trial Supply & Logistics for Pharmaceutical Market
13.1. Introduction
14. Pennsylvania Clinical Trial Supply & Logistics for Pharmaceutical Market
14.1. Introduction
15. Texas Clinical Trial Supply & Logistics for Pharmaceutical Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Almac Group
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. AmerisourceBergen Corporation
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. Bilcare Limited
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Biocair International Limited
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. Catalent, Inc.
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Clinigen Group PLC
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. DHL International GmbH by Deutsche Post AG
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Eurofins Scientific SE
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. FedEx Corporation
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. ICON PLC
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. Infosys Limited
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. KLIFO A/S
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Lonza Group
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Marken
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. Metrics Contract Services by Mayne Pharma group
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. Movianto
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. N-Side
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
17.18. Parexel International Corporation
17.18.1. Business Overview
17.18.2. Key Executives
17.18.3. Product & Services
17.19. PCI Pharma Services
17.19.1. Business Overview
17.19.2. Key Executives
17.19.3. Product & Services
17.20. Seveillar Clinical Trial Supplies Pvt. Ltd.
17.20.1. Business Overview
17.20.2. Key Executives
17.20.3. Product & Services
17.21. SIRO Clinpharm Private Limited
17.21.1. Business Overview
17.21.2. Key Executives
17.21.3. Product & Services
17.22. Thermo Fisher Scientific, Inc.
17.22.1. Business Overview
17.22.2. Key Executives
17.22.3. Product & Services
17.23. UDG Healthcare PLC
17.23.1. Business Overview
17.23.2. Key Executives
17.23.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET DYNAMICS
FIGURE 8. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY PHASE, 2027
FIGURE 11. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2021 VS 2027 (%)
FIGURE 17. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY SECTOR, 2027
FIGURE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (%)
FIGURE 23. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE STRATEGIC WINDOW, BY THERAPEUTIC AREA, 2027
FIGURE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 29. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
FIGURE 30. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 37. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 38. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 39. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2021
TABLE 3. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BA/BE STUDIES, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE I, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE II, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE III, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE IV, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL LOGISTICS AND DISTRIBUTIONS, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING SERVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIAL SUPPLY CHAIN MANAGEMENT, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY BLOOD DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY DIGESTIVE SYSTEM DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY INFECTIOUS AND IMMUNE SYSTEM DISEASES, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY NEUROLOGICAL AND MENTAL DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, 2018-2027 (USD MILLION)
TABLE 33. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 34. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 35. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 36. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 37. CALIFORNIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 38. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 39. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 40. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 41. FLORIDA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 42. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 43. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 44. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 45. ILLINOIS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 46. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 47. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 48. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 49. NEW YORK CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 50. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 51. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 52. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 53. OHIO CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 54. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 55. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 57. PENNSYLVANIA CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 58. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 59. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY PHASE, 2018-2027 (USD MILLION)
TABLE 60. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY SECTOR, 2018-2027 (USD MILLION)
TABLE 61. TEXAS CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 63. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 64. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 65. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET RANKING, BY KEY PLAYER, 2021
TABLE 66. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2021
TABLE 67. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET MERGER & ACQUISITION
TABLE 68. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 69. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 70. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET INVESTMENT & FUNDING
TABLE 71. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 72. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS FOR PHARMACEUTICAL MARKET: LICENSE & PRICING

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings